Connect with us


Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial – The New York Times

An antiviral widely used to treat hospitalized patients did not lower the mortality rate in a multinational trial.



post featured image

The W.H.O.s study, called the Solidarity trial, enrolled more than 11,300 adults with Covid-19 in 405 hospitals in 30 countries. The participants were given four drugs singly or in combination: remdesivir, hydroxychloroquine, lopinavir, interferon or interferon plus lopinavir. About 4,100 received no drug treatment.
In the end, no drug or combination reduced mortality, the chances that mechanical ventilation would be needed, or time spent in the hospital, compared with the patients without drug…

Click here to view the original article.

You might also like ...

post featured image
‘The next wave has started.’ Capital Region braces as COVID-19 numbers grow – Times Union
post featured image
Some COVID-19 antibodies attack the body, not the virus: study – New York Post
post featured image
NYC business owner: State inspectors unfairly targeted closed store for alleged coronavirus violations – Fox News